As an increasing number of clinical decision-support systems driven by artificial intelligence progress from development to implementation, better guidance on the reporting of human factors and early-stage clinical evaluation is needed.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Keane, P. A. & Topol, E. J. npj Digital Med. 1, 40 (2018).
Collins, G. S. & Moons, K. G. M. Lancet 393, 1577–1579 (2019).
Sounderajah, V. et al. Nat. Med. 26, 807–808 (2020).
Liu, X., Rivera, S. C., Moher, D., Calvert, M. J. & Denniston, A. K. Br. Med. J. 370, m3164 (2020).
McCulloch, P. et al. Lancet 374, 1105–1112 (2009).
Hirst, A. et al. Ann. Surg. 269, 211–220 (2019).
Bilbro, N. A. et al. Ann. Surg. 273, 82–85 (2021).
Price, W. N. II, Gerke, S. & Cohen, I. G. J. Am. Med. Assoc. 322, 1765–1766 (2019).
Dalkey, N. & Helmer, O. Manage. Sci. 9, 458–467 (1963).
Powell, C. J. Adv. Nurs. 41, 376–382 (2003).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
X.L. is an industry fellow (observer) with Hardian Health. D.A.C. declares academic grants from GlaxoSmithKline and personal fees from Oxford University Innovation, Biobeats and Sensyne Health, outside the context of this work. B.F.G. is CEO and Founder of Healthplus.ai and declares consulting fees from NLC Ventures Netherlands. L.M. is director and owner of Morgan Human Systems. P.W. reports grants from National Institute for Health Research, grants from Wellcome, grants from Sensyne Health, and personal fees from Sensyne Health, outside the submitted work.
Rights and permissions
About this article
Cite this article
The DECIDE-AI Steering Group. DECIDE-AI: new reporting guidelines to bridge the development-to-implementation gap in clinical artificial intelligence. Nat Med 27, 186–187 (2021). https://doi.org/10.1038/s41591-021-01229-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01229-5
This article is cited by
-
Deep learning supported discovery of biomarkers for clinical prognosis of liver cancer
Nature Machine Intelligence (2023)
-
Take a Load Off: Understanding, Measuring, and Reducing Cognitive Load for Cardiologists in High-Stakes Care Environments
Current Treatment Options in Pediatrics (2023)
-
Artificial Intelligence and Cancer Control: Toward Prioritizing Justice, Equity, Diversity, and Inclusion (JEDI) in Emerging Decision Support Technologies
Current Oncology Reports (2023)
-
An explanation space to align user studies with the technical development of Explainable AI
AI & SOCIETY (2023)
-
Evaluating and reducing cognitive load should be a priority for machine learning in healthcare
Nature Medicine (2022)